TrialBlood cancer journal2022

Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients.

Cinzia Borgogna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.